Back to results
US 6,274,580 B1Granted
Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
AssigneePharmacia & Upjohn Company
InventorsScott D. Larsen, Martin D. Meglasson, Valerie A. Vaillancourt, Paul D. May
Life of this patent
Estimating the term…
Abstract
Compounds selected from the group consisting of formulae I, II, III, IV, VI, VII, and VIII wherein R is H or NH2, and pharmacologically acceptable salts thereof, are suitable for use in methods for treating non-insulin-dependent diabetes mellitus (NIDDM) or obesity in a patient susceptible to or experiencing NIDDM or obesity by the systemic administration of such a compound in an amount effective to treat the NIDDM or obesity.
Claims23
A compound selected from the group consisting of formulae I, II, III, IV, VI, VII, and VIII
- wherein R is H or NH2, and pharmacologically acceptable salts thereof, with the proviso that in formula II at least one R group must be NH2.
Dependencies are inferred from the claim text.